Article
Author(s):
Toronto - A group of Canadian physicians who use Artecoll, an injectable currently awaiting FDA approval, is calling for the development of formal clinical guidelines and further research to help avoid adverse patient reactions.
Review Compares Psoriasis Therapies in Asian Populations
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Subgroup Analysis Reveals Equal Benefit of Brodalumab in Obese vs Non-Obese Patients With Psoriasis
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Patients Treated for Acne Exhibit Higher Sebum, Hydration, and TEWL Levels than General Population
Exploring the Atopic Dermatitis Treatment Paradigm and Challenging Cases